Arun V J: Don’t Miss TRANSCON 2026 – A Direct Pathway Into India’s Clinical and Institutional Network
Arun V J, The Leader of Transfusion Medicine at Malabar Medical College, shared a post on LinkedIn:
”If you’re in Blood Banking, Transfusion Medicine, MedTech, IVD, diagnostics, or healthcare marketing, India is no longer a ‘next’ market – it’s a current growth priority.
With one of the fastest-expanding healthcare ecosystems globally, the real question is not if you enter – but how effectively you engage the right stakeholders.
Welcome to India’s largest gathering of Blood Banking/Transfusion Medicine Professionals.
TRANSCON 2026 (18–20 September | Kochi, India) is designed for exactly that.
It brings together:
- Clinicians and transfusion specialists
- Policy influencers and program leaders
- Hospital decision-makers and academic experts
- Industry partners across blood banking, diagnostics, and advanced therapies
This is not a conventional conference or passive exhibition.
It is a working interface where:
- technologies are critically evaluated – not just displayed
- procurement pathways and collaborations begin
- market understanding moves from theory to real conversations
With 1000+ delegates and 100+ national and international faculty, the engagement is both high-density and decision-focused.
If your organisation is working in:
- Blood Banking and Transfusion Medicine
- Apheresis and Cellular Therapies
- Diagnostics and Immunohematology
- AI, Automation and Digital Health
- Plasma, Fractionation and Biologics
This platform offers a direct pathway into India’s clinical and institutional network.
The attached brochure outlines:
- Scientific tracks and emerging themes
- Pre-conference workshops (AI, apheresis, transplant immunology, regenerative medicine)
- Industry engagement opportunities
India is scaling rapidly across healthcare delivery, infrastructure, and technology adoption.
TRANSCON 2026 is where global innovation meets this scale.
If India is part of your strategic roadmap, this is a high-value touchpoint.”

Stay updated with Hemostasis Today.
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target
-
Oct 7, 2026, 15:28Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
-
Oct 7, 2026, 15:21Eloïse Laouenan: Bridging Immunity and Thrombosis in MVTE
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story